1. Introduction: Galicia Clínica is the official journal of the Galician Society of Internal Medicine (SOGAMI). Galicia Clínica will assess the publication of medical papers preferably related to Internal Medicine and its subspecialties and/or prevalent medical problems in the Autonomous Community of Galicia. There is a form for sending originals on the website www.galiciaclinica.info. The system will confirm delivery and will allow you to check the status of the manuscript. Originals sent by other methods will not be accepted. The editorial committee, with the help of two reviewers, will evaluate the submitted papers, deciding whether to proceed with publication, if corrections are necessary, or if the publication is rejected. Once accepted, the printing proofs will be sent to the author for corrections.

2. Types of publications.

*Editorials. They are always requested by the Editorial Committee. The maximum length of the text will be 2000 words with a maximum of 10 citations. The number of authors will not exceed 2.

*Reviews. Reviews on current issues in Internal Medicine will be considered, usually commissioned by the Editorial Committee. Any author can send works to this section that will be valued by the Editorial Committee of the journal. It must present the following structure: Title (in Spanish and English), Abstract (in Spanish and English), Keywords, Introduction, Review and Conclusions. The maximum length of the text will be 4000 words (excluding Abstract, References and the legends of the figures and tables). A maximum of 6 tables or figures may be included. The References will have a maximum of 50 citations. The summary must be done in Spanish and English and will have a maximum length of 250 words; it is not necessary to follow a specific structure. The number of authors will not exceed 3.

*Originals. Original research works such as randomized clinical trials, cohort studies, cost-effectiveness analysis, case-control studies, cross-sectional studies, and survey-based studies with high response rates will be considered. The article must present the following structure: Title (in Spanish and English), Structured Abstract, Keywords, Introduction, Material and Methods, Results, Discussion and Conclusions and References (maximum 30). The maximum length of the text will be 3000 words (excluding Abstract, References and the legends of the figures and tables). A maximum of 5 tables or figures may be added. The summary must be in Spanish and English and will have a maximum length of 250 words and must be structured in the following headings: Aims, Material and Methods, Results and Conclusions. The number of authors will not exceed 8.

*Short originals. Original research papers will be considered which, due to their characteristics, can be published in an abbreviated form. They will be structured as the original articles. The maximum length of the text will be 1500 words (excluding Abstract, References and the legends of the figures and tables). A maximum of 3 tables or figures may be included. The references will have a maximum of 15 citations. The summary must be in Spanish and English and will have a maximum length of 250 words and must be structured in the following headings: Aims, Material and Methods, Results and Conclusions. The number of authors will not exceed 6.

*Clinical cases. Clinical cases of exceptional interest will be considered. It must present the following structure: Title (in Spanish and English), Abstract, Clinical Case, Discussion and References. The maximum length of the text will be 1000 words (excluding Abstract, References and the legends of the figures and tables). A maximum of 3 tables or figures may be included. The References will have a maximum of 10 citations. The abstract will have a maximum length of 150 words, and it is not necessary to follow a specific structure. The number of authors will not exceed 4.

*Letters to the Editor. Comments or opinions on works previously published in the journal will be considered. The maximum length of the text will be 1000 words. A maximum of 1 table or figure and 10 citations may be included.

*Medical images. Images that have a particular interest will be considered. The image must be of high quality. It is recommended to use resources such as arrows or marks to clarify the image. They will be accompanied by a brief text of a maximum length of 250 words and a maximum of 3 citations. The number of authors will not exceed 2.

3. Language. This magazine is published in Spanish and English. Either language must be grammatically and orthographically correct. In the case of English, American or British is accepted, but not a mixture of them.

4. Before uploading the manuscript. The submitted article cannot have been previously published (except in the form of a communication to a scientific conference or as a doctoral thesis) or be subject to review by another journal at the time of submission. The papers will meet the usual uniformity requirements in biomedical journals. These requirements can be found in "Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication, Updated April 2010", available at https://www.icmje.org. It is strongly recommended to read the section "Preparing a Manuscript for Submission to a Biomedical Journal" https://www.icmje.org/recommendations/browse/manuscript-preparation/ and faithfully follow its instructions when writing the manuscript.

5. Authorship. All authors must have made contributions to the article. For more information, see the authorship requirements outlined by the ICMJE (https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html)

6. Files. The files and tables must be made in Word®. The text should be in Times New Roman size 12 with single spacing (1.0). Photographs, images or graphic files will be sent as PDF or as an image file (JPEG or similar). Every article sent must contain the following files: Presentation letter, Title page: it must contain the title (in Spanish and English), the authors with their affiliation data, correspondence author (postal address and email must be specified), Manuscript: is the body of the publication; it will be scheduled according to the different types of articles as specified in the previous section, Images: Photographs, images or graphic files must be high quality with a resolution of 300 dpi. to final print size. Otherwise, they cannot be published. As a guideline, it can be considered that the file containing an image will have a size of no less than 500 KB.

7. Keywords. Each article must have 3 to 5 keywords (in Spanish and English). Use the MESH terms (Medical Subjects Headings) from the Index Medicus.

8. References. Check that each reference cited in the text appears in the reference list. Cite references within the text with superscript numbers. List the references in the same order that they appear in the text following the format recommended by the ICMJE. Examples: Reference to a journal article: Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347(4):284-7. If the list of authors is greater than six, the first six will be named followed by “et al.”. Reference to a book: Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002. Reference to a chapter of a book: Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113. Reference to a web page: eatright.org [Internet]. Chicago: Academy of Nutrition and Dietetics; c2016 [cited 2016 Dec 27]. Available from: https://www.eatright.org/ For any other reference see https://www.nlm.nih.gov/bsd/uniform_requirements.html

9. Acknowledgments. It will include all those people who have contributed to the preparation of the article but who do not meet the authorship criteria.

10. Funding. The authors must specify if the research has received any source of funding.

11. Conflicts of interest. Authors must declare all possible conflicts of interest in the form of personal or financial relationships that could be related to the results of the article. If there are no conflicts of interest, the authors must also include it in a section of the manuscript with the phrase: “there are no conflicts of interest”.

12. Abbreviations. It is necessary to define any abbreviation used in the text the first time it is used.

13. Ethical issues. Authors must have carried out their research in accordance with the guidelines of the Declaration of Helsinki and the standards of good clinical practice, as well as current legislation. Informed consent: In any clinical study, authors must have the authorization of the corresponding ethics committee as well as have written informed consent (or exemption from the need for it by the ethics committee). In the case of publishing clinical cases, the authors must have the patient's authorization to publish the case and must ensure that no data from it can make it recognizable. The photographs must not be identifying (if the patient's face is included, the orbital region will be covered with opaque black tape) and a written authorization from the patient for the publication of such photographs must also be included. In all works including patients, written informed consent for their participation in them must be made explicit. The right to privacy of individuals must be always guaranteed. Experimentation on human subjects: Research and scientific experimentation on the human being constitute a right and a duty of the scientific and biomedical community. Scientific experimentation is an important way of knowledge about human nature. This knowledge should be used to increase the well-being, health and quality of life of the human being. In the case of works where experimentation is carried out on human beings, the following items must be specified in an independent document that will be attached to the article: In research on the human being, the interests of science and society can never prevail over the welfare of the subject. The right of the subject to protect his integrity must always be respected. All precautions must be taken to preserve the physical and psychological integrity of the people who participate as experimental subjects. Experimentation with human beings that may cause risks or discomfort to the subjects should only be carried out when there are no alternative procedures of comparable efficacy. Biomedical research in humans must be in accordance with commonly accepted ethical and scientific standards and will be based on risk assessment based on previous experiments, correctly carried out in the laboratory and on animals, and a reasonable knowledge of the possible consequences. of the experiment. No experiment can be done on a person unless there is no alternative method to the experiment on human beings of comparable efficacy. Proportionality between benefits and risks of research. The risks or inconveniences involved in experimentation on human beings will not be disproportionate nor will they imply a reduction in moral conscience or their dignity. In the case of biomedical research, the importance of the objectives will be proportional to the risk that the subjects run for it. Any biomedical research project involving human beings must be preceded by a careful calculation of the foreseeable risks and their comparison with the benefits that may be derived for the research subject and for other individuals. Concern for the interests of the person investigated must always prevail over the interests of science and society. Any research or experiment should be stopped if the risks are found to outweigh the calculated benefits. Participation in any investigation or experiment will imply the free and informed consent of the experimental subject after receiving adequate information about the nature and purpose of the experiment, the objectives, the methods, the calculated benefits and the possible risks or discomforts that may be involved. Subjects may freely withdraw their consent at any time, without being harmed. If they participate in the research or minor experiments or people with disabilities with diminished competence or autonomy, the consent will always be granted in writing by their legal representative or whoever has the duty to care for them. If the researchers offer the subjects incentives or economic rewards or of any other type for their participation in the research or the experiment, this will not be so high that it cannot be reasonably rejected by the subject. Researchers have the duty to guarantee the right to privacy of the subjects. In teamwork, each investigator is responsible for the entirety of the secret. All participants in research on human subjects will keep the strictest confidentiality so that the personal or family privacy of the subjects participating in it is not violated. In all research or scientific experiments, experimental subjects or participants must be treated with the greatest respect for their dignity, beliefs, privacy and modesty, especially protection for the most vulnerable people. In any experiment or scientific investigation, the identity of the researcher or researchers responsible for it, as well as that of the rest of the research team that collaborates in it, must be clearly defined. The responsibility derived from the research will always fall on the researcher, never on the research subject himself, even if he has given his informed consent. The approval of the experimental protocols by an ethics committee does not exempt the researchers from their direct responsibility. Animal experimentation: If part of the research work has been carried out on animals, the work must also meet the required requirements and the authorization of the corresponding Clinical Research Committee. Animal experiments should adhere to the ARRIVE guidelines (https://arriveguidelines.org/) and be conducted in accordance with the UK Animals (Scientific Procedures) Act 1986 and related recommendations of EU Directive 2010/63 /EU (https://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm) for animal experiments, or the National Institutes of Health guide on the care and use of laboratory animals (NIH Publications No. 8023, revised 1978). The author must clearly indicate in the manuscript that these guidelines have been followed. Galicia Clínica will only evaluate works that include animal experimentation when it pursues the following purposes: The prevention of diseases, health disorders and other anomalies or their effects, as well as their diagnosis and treatment in humans, vertebrate or invertebrate animals or plants; the development and manufacture of pharmaceutical and food products and other substances or products, as well as the performance of tests to verify their quality, efficacy and safety. The assessment, detection, establishment or modification of physiological conditions in humans, vertebrate or invertebrate animals or plants. The protection of the natural environment, for the benefit of the health or well-being of human beings, vertebrate or invertebrate animals or plants. Scientific research. Education and training. The medical-legal investigation.